{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "ACE2 receptor",
      "COVID-19",
      "SARS-CoV-2"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "33170317",
  "DateCompleted": {
    "Year": "2020",
    "Month": "12",
    "Day": "17"
  },
  "DateRevised": {
    "Year": "2021",
    "Month": "01",
    "Day": "10"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2020",
        "Month": "11",
        "Day": "10"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1007/s00408-020-00408-4"
    ],
    "Journal": {
      "ISSN": "1432-1750",
      "JournalIssue": {
        "Volume": "198",
        "Issue": "6",
        "PubDate": {
          "Year": "2020",
          "Month": "Dec"
        }
      },
      "Title": "Lung",
      "ISOAbbreviation": "Lung"
    },
    "ArticleTitle": "ACE2: The Major Cell Entry Receptor for SARS-CoV-2.",
    "Pagination": {
      "StartPage": "867",
      "EndPage": "877",
      "MedlinePgn": "867-877"
    },
    "Abstract": {
      "AbstractText": [
        "Despite the unprecedented effort of the scientific community, the novel SARS-CoV-2 virus has infected more than 46 million people worldwide, killing over one million two hundred thousand. Understanding the mechanisms by which some individuals are more susceptible to SARS-CoV-2 infection and why a subgroup of them are prone to experience severe pneumonia, and death should lead to a better approach and more effective treatments for COVID-19. Here, we focus our attention on ACE2, a primary receptor of SARS-CoV-2. We will discuss its biology, tissue expression, and post-translational regulation that determine its potential to be employed by SARS-CoV-2 for cell entry. Particular attention will be given to how the ACE2 soluble form can have a great impact on disease progression and thus be used in a potential therapeutic strategy. Furthermore, we will discuss repercussions that SARS-CoV-2/ACE2 binding has on the renin-angiotensin system and beyond. Indeed, although mostly neglected, ACE2 can also act on [des-Arg 937]-bradykinin of the kinin-kallikrein system regulating coagulation and inflammation. Thorough comprehension of the role that ACE2 plays in different pathways will be the key to assess the impact that SARS-CoV-2/ACE2 binding has on organismal physiology and will help us to find better therapies and diagnostic tools."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Dipartimento di Scienze Mediche Traslazionali, University of Campania \"L. Vanvitelli\", Naples, Italy."
          },
          {
            "Identifier": [],
            "Affiliation": "CEINGE, Biotecnologie Avanzate, Naples, Italy."
          }
        ],
        "LastName": "Scialo",
        "ForeName": "Filippo",
        "Initials": "F"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Dipartimento di Scienze e Tecnologie Ambientali Biologiche Farmaceutiche, University of Campania \"L. Vanvitelli\", Naples, Italy."
          },
          {
            "Identifier": [],
            "Affiliation": "CEINGE, Biotecnologie Avanzate, Naples, Italy."
          }
        ],
        "LastName": "Daniele",
        "ForeName": "Aurora",
        "Initials": "A"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Universit\u00e0 Di Napoli Federico II, Naples, Italy."
          },
          {
            "Identifier": [],
            "Affiliation": "CEINGE, Biotecnologie Avanzate, Naples, Italy."
          }
        ],
        "LastName": "Amato",
        "ForeName": "Felice",
        "Initials": "F"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Universit\u00e0 Di Napoli Federico II, Naples, Italy."
          },
          {
            "Identifier": [],
            "Affiliation": "CEINGE, Biotecnologie Avanzate, Naples, Italy."
          }
        ],
        "LastName": "Pastore",
        "ForeName": "Lucio",
        "Initials": "L"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Dipartimento di Medicina Sperimentale, University of Campania \"L. Vanvitelli\", Naples, Italy."
          }
        ],
        "LastName": "Matera",
        "ForeName": "Maria Gabriella",
        "Initials": "MG"
      },
      {
        "Identifier": [
          "0000-0003-4895-9707"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Dipartimento di Medicina Sperimentale, University of Rome \"Tor Vergata\", Rome, Italy. mario.cazzola@uniroma2.it."
          }
        ],
        "LastName": "Cazzola",
        "ForeName": "Mario",
        "Initials": "M"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Universit\u00e0 Di Napoli Federico II, Naples, Italy."
          },
          {
            "Identifier": [],
            "Affiliation": "CEINGE, Biotecnologie Avanzate, Naples, Italy."
          }
        ],
        "LastName": "Castaldo",
        "ForeName": "Giuseppe",
        "Initials": "G"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Dipartimento di Scienze Mediche Traslazionali, University of Campania \"L. Vanvitelli\", Naples, Italy."
          }
        ],
        "LastName": "Bianco",
        "ForeName": "Andrea",
        "Initials": "A"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Review"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "Lung",
    "NlmUniqueID": "7701875",
    "ISSNLinking": "0341-2040"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Receptors, Coronavirus"
    },
    {
      "RegistryNumber": "EC 3.4.17.23",
      "NameOfSubstance": "Angiotensin-Converting Enzyme 2"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "physiology"
      ],
      "DescriptorName": "Angiotensin-Converting Enzyme 2"
    },
    {
      "QualifierName": [
        "diagnosis",
        "etiology",
        "therapy"
      ],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "physiology"
      ],
      "DescriptorName": "Receptors, Coronavirus"
    },
    {
      "QualifierName": [
        "physiology"
      ],
      "DescriptorName": "Renin-Angiotensin System"
    },
    {
      "QualifierName": [
        "physiology"
      ],
      "DescriptorName": "SARS-CoV-2"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Virus Internalization"
    }
  ],
  "CoiStatement": "The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper."
}